Username:
Password:
Forgot Password?
Remember me
Decade: 2010-2010 2000-2009 1990-1999 1980-1989 1970-1979
Year: 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Issues: Vol. 102 No. 12 December 22, 2008 p.1L-50L-Supplement Vol. 102 No. 12 December 15, 2008 p.1577-1746 Vol. 102 No. 11 December 1, 2008 p.1427-1576 Vol. 102 No. 10 November 17, 2008 p.1K-36K-Supplement Vol. 102 No. 10 November 15, 2008 p.1285-1426 Vol. 102 No. 9 November 3, 2008 p.1J-38J-Supplement Vol. 102 No. 9 November 1, 2008 p.1119-1284 Vol. 102 No. 8 October 15, 2008 p.957-1118 Vol. 102 No. 8 October 12, 2008 p.1I-270I-Supplement Vol. 102 No. 7 October 1, 2008 p.797-956 Vol. 102 No. 6 September 22, 2008 p.1H-32H-Supplement Vol. 102 No. 6 September 15, 2008 p.649-796 Vol. 102 No. 5 September 8, 2008 p.1G-68G-Supplement Vol. 102 No. 5 September 1, 2008 p.509-648 Vol. 102 No. 4 August 15, 2008 p.375-508 Vol. 102 No. 3 August 1, 2008 p.249-374 Vol. 102 No. 2 July 15, 2008 p.115-248 Vol. 102 No. 1 July 1, 2008 p.1-114 Vol. 101 No. 12 June 16, 2008 p.S1-S2-Supplement Vol. 101 No. 12 June 15, 2008 p.1683-1810 Vol. 101 No. 11 June 2, 2008 p.S1-S116-Supplement Vol. 101 No. 11 June 1, 2008 p.1523-1682 Vol. 101 No. 10 May 22, 2008 p.S1-S86-Supplement Vol. 101 No. 10 May 15, 2008 p.1373-1524 Vol. 101 No. 9 May 1, 2008 p.1219-1372 Vol. 101 No. 8 April 23, 2008 p.S1-S108-Supplement 2 Vol. 101 No. 8 April 17, 2008 p.S1-S62-Supplement Vol. 101 No. 8 April 15, 2008 p.1073-1218 Vol. 101 No. 7 April 1, 2008 p.911-1072 Vol. 101 No. 6 March 15, 2008 p.747-910 Vol. 101 No. 5 March 1, 2008 p.557-746 Vol. 101 No. 4 February 15, 2008 p.419-556 Vol. 101 No. 3 February 4, 2008 p.S1-S96-Supplement Vol. 101 No. 3 February 1, 2008 p.279-418 Vol. 101 No. 2 January 15, 2008 p.139-278 Vol. 101 No. 1 January 1, 2008 p.1-138
The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia
Edited by Jean-Charles Fruchart PhD, Frank M. Sacks MD, Michel P. Hermans MD, PhD
Publication of this supplement was supported by Solvay Pharmaceuticals and Abbott Laboratories.
Search Within This Issue
3 Articles:
Despite achieving targets for low-density lipoprotein (LDL) cholesterol, blood pressure, and glycemia in accordance with current standards of care, patients with dyslipidemia remain at high residual r...
